Distinguished in Anal Cancer

Dr. Natalie Workman

Hematology | Oncology
Cheyenne Regional Cancer Center-Natalie Alana Workman, MD
310 E 24th St, 
Cheyenne, WY 
Distinguished in Anal Cancer
Cheyenne Regional Cancer Center-Natalie Alana Workman, MD
310 E 24th St, 
Cheyenne, WY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Natalie Workman is a Hematologist and an Oncologist in Cheyenne, Wyoming. Dr. Workman is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. Her top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Colorectal Cancer.

Her clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Oncology
Licenses
Internal Medicine in WY
Hospital Affiliations
Community Hospital
Platte County Hospital
Cheyenne Regional Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Mountain Health
  • OTHER COMMERCIAL
  • POS
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Cheyenne Regional Cancer Center-Natalie Alana Workman, Md
310 E 24th St, Cheyenne, WY 82001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
A Phase III, Open-label, Multicenter Trial of Avelumab (MSB0010718C) Versus Platinum-based Doublet as a First-line Treatment of Recurrent or Stage IV PD-L1+NSCLC
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Avelumab, Pemetrexed, Paclitaxel, Gemcitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
COMPLEEMENT-1: An Open-label, Multicenter, Phase IIIb Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With Hormone Receptor-positive (HR+) HER2-negative (HER2-) Advanced Breast Cancer (aBC) With no Prior Hormonal Therapy for Advanced Disease
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drugs: Ribociclib, Letrozole, Goserelin, Leuprolide
Study Phase: Phase 3
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
Enrollment Status: No_longer_available
Publish Date: July 15, 2020
Intervention Type: Drug
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Enrollment Status: Terminated
Publish Date: May 28, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Distinguished in Anal Cancer
Dr. Steven Gamalski
Hematology
Distinguished in Anal Cancer
Dr. Steven Gamalski
Hematology

Henry Ford Hospital

1800 15th St Ste 100B, 
Greeley, CO 
 (50.4 miles away)
313-916-2600
Languages Spoken:
English
See accepted insurances

Steven Gamalski is a primary care provider, practicing in Hematologist in Greeley, Colorado. Dr. Gamalski is rated as an Advanced provider by MediFind in the treatment of Anal Cancer. His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Trisomy 3 Mosaicism, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Advanced in Anal Cancer
Dr. Ross Mcfarland
Hematology
Advanced in Anal Cancer
Dr. Ross Mcfarland
Hematology

Poudre Valley Health Care Inc.

2121 E Harmony Rd Unit 170, 
Fort Collins, CO 
 (45.7 miles away)
970-493-6337
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ross Mcfarland is a Hematologist in Fort Collins, Colorado. Dr. Mcfarland is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Melanoma, Gastroesophageal Junction Cancer, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Advanced in Anal Cancer
Dr. John M. Schallenkamp
Radiation Oncology | Hematology | Oncology
Advanced in Anal Cancer
Dr. John M. Schallenkamp
Radiation Oncology | Hematology | Oncology

Memorial Hospital Of Laramie County

214 E 23rd St, 
Cheyenne, WY 
 (0.1 miles away)
307-634-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Schallenkamp is a Radiation Oncologist and a Hematologist in Cheyenne, Wyoming. Dr. Schallenkamp is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. His top areas of expertise are Lung Cancer, Astrocytoma, Familial Prostate Cancer, Endoscopy, and Prostatectomy. Dr. Schallenkamp is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Workman's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 29 Advanced Conditions
    View All 149 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile